Exercise Training in Patients With Chagasic Heart Disease Without Ventricular Dysfunction

Chagas disease

An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About the Risk of Pregnancy Complications and About the Mother’s and Baby’s Health SBRT in Chagas Disease Ventricular Tachycardia Atorvastatin on Inflammation and Cardiac Function in Chronic Chagas Disease New Scheme for Treatment With Benznidazole Outcomes of an Anticoagulation Clinic in an University Hospital Cardiac Rehabilitation in Chagas Heart Failure Impact of the Pharmaceutical Care on the Quality of Life in Patients With Chagas Heart Disease Exercise Training in Chagas Cardiomyopathy Genetic Architecture of Heart Disease in Rural Brazil Physical Exercise Program in Chronic Chagas Heart Disease Effect of Ganglionar Electrical Stimulation on Central Arterial Pressure Abbott ESA Chagas Assay Post-Market Study Pharmacokinetic Drug-Drug Interaction Study Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age Population Pharmacokinetics Study of Benznidazole in Children With Chagas’Disease Exercise Training in Patients With Chagasic Heart Disease Without Ventricular Dysfunction Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States Colchicine for Patients With Chagas´ Disease( B1 Stage) Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mg Longitudinal Study of Patients With Chronic Chagas Cardiomyopathy in Brazil (SaMi_Trop Project) Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas’ Patients Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas’ Patients Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas’ Patients – Dietary Habits Study BENDITA BEnznidazole New Doses Improved Treatment and Associations Selenium Treatment and Chagasic Cardiopathy (STCC) Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease Renal Denervation in Patients With Heart Failure Secondary to Chagas Disease Congenital Transmission of Lineages I and II of Trypanosoma Cruzi New Therapies and Biomarkers for Chagas Infection Determination of Genetic Polymorphisms in Chronic Chagas Cardiomyopathy Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole Population Pharmacokinetics in Benznidazole-treated Adults With Chronic With Chagas Disease Prospective Study of Benznidazole for Chagas’ Disease Children With Chronic Indeterminate Chagas Disease Optimization of PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas Disease Reveal Chagas: Clinical Evidence of the Implantable Cardiac Monitor in Patients With Chagas Disease Prospective Study of a Pediatric Nifurtimox Formulation for Chagas’ Disease Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease. A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267) Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease Congenital Chagas Disease: Long Term Follow up of Treated Children. Preliminary Report or Cardiological Evaluation in Chagas Disease Treated Children Nifurtimox Versus Benznidazole Effectiveness and Tolerance for Chagas Disease Treatment Syndecan-4 as a Biomarker in Patients With Chagas Disease Population Pharmacokinetics of Benznidazole in Children With Chagas Disease Study of Benznidazole Transfer Into Breastmilk in Lactating Women With Chagas Disease New Tools for the Diagnosis, Prognosis and Treatment Follow-up in Chagas Disease MicroRNAs as Biomarkers in Patients With Chagas Disease Galectin-3 as a Biomarker in Patients With Chagas Disease Study on Benefits of Therapy With Nifurtimox in Chagas Disease, a Parasitic Illness Mostly Transmitted to Humans by a Bug, Using Information From Patient Medical Records in Argentina Assessment of Speckle Tracking Strain Predictive Value for Myocardial Fibrosis in Chagas Disease